Document is current

Any future updates will be listed below

Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study

Crossref DOI link: https://doi.org/10.1007/s12264-016-0020-2

Published Online: 2016-03-09

Published Print: 2016-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark